Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of anti-inflammatory and analgesic agents. Its structure supports the design of drugs targeting cyclooxygenase (COX) enzymes, making it valuable in creating non-steroidal anti-inflammatory drugs (NSAIDs). Also employed in research for optimizing metabolic stability and bioavailability in drug candidates due to the presence of the methylsulfonyl group, which can influence solubility and binding properties.